A SAFETY, TOLERABILITY, AND PHARMACOKINETICS STUDY OF A SINGLE INTRAVENOUS INJECTION OF RECOMBINANT COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN (RFVIIIFC-VWF-XTEN) (BIVV001) IN PREVIOUSLY TREATED ADULTS WITH SEVERE HEMOPHILIA A (EXTEN-A):